Chernopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice

被引:37
作者
Raina, Komal [1 ]
Rajamanickam, Subapriya [1 ]
Singh, Rana P. [1 ,3 ]
Agarwal, Rajesh [1 ,2 ]
机构
[1] Univ Colorado, Dept Pharmaceut Sci, Sch Pharm, Denver, CO 80262 USA
[2] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
[3] Jawaharlal Nehru Univ, Sch Life Sci, Canc Biol Lab, New Delhi 110067, India
关键词
D O I
10.1158/1078-0432.CCR-07-5275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Herein, for the first time, we evaluated the in vivo chemopreventive efficacy of inositol hexaphosphate (IP6), a major constituent of high-fiber diets, against prostate tumor growth and progression in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Experimental Design: Beginning at 4 weeks of age, male TRAMP mice were fed 2% (w/v) IP6 in drinking water or only drinking water till 24 weeks of age, and then sacrificed. Prostate tissue was subjected to histopathologic analysis and to immunohistochemical analyses for proliferation and apoptosis. Results: IP6 feeding did not show any adverse effect on fluid and diet consumption and body weight. There was a significant reduction (40%; P < 0.01) in lower urogenital tract weight in IP6-fed mice. IP6 inhibited prostate cancer progression at prostatic intraepithelial neoplasia stage and strongly reduced the incidence of adenocarcinoma (prostatic intraepithelial neoplasia/adenocarcinoma, 75:25% in the IP6 group versus 39:61% in the control group; P < 0.05). The incidences of well-differentiated and poorly differentiated adenocarcinomas in the IP6-fed group were reduced by 44% and 62%, respectively. Immunohistochemical analysis of prostate tissue showed a 26% decrease (P < 0.05) in proliferation cell nuclear antigen - positive cells and a 3.5-fold increase in apoptotic cells with no effect on Tag expression by IP6. Conclusions: These findings are both novel and highly significant in establishing for the first time that oral IP6, without any toxicity, suppresses prostate tumor growth and progression at the neoplastic stage, thereby reducing the incidence of adenocarcinoma through its antiproliferative and proapoptotic effects, and thus indicating that IP6 could have potential chemopreventive effects against human prostate cancer.
引用
收藏
页码:3177 / 3184
页数:8
相关论文
共 44 条
[1]   Role of diet modification in cancer prevention [J].
Abdulla, M ;
Gruber, P .
BIOFACTORS, 2000, 12 (1-4) :45-51
[2]   Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells [J].
Agarwal, C ;
Dhanalakshmi, S ;
Singh, RP ;
Agarwal, R .
NEOPLASIA, 2004, 6 (05) :646-659
[3]  
Agarwal C, 2003, ANTICANCER RES, V23, P3855
[4]   Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents [J].
Agarwal, R .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) :1051-1059
[5]   Macronutrients, fatty acids, cholesterol and prostate cancer risk [J].
Bidoli, E ;
Talamini, R ;
Bosetti, C ;
Negri, E ;
Maruzzi, D ;
Montella, M ;
Franceschi, S ;
La Vecchia, C .
ANNALS OF ONCOLOGY, 2005, 16 (01) :152-157
[6]   The epidemiology of prostate cancer [J].
Boyle, P ;
Severi, G ;
Giles, GG .
UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (02) :209-+
[7]   Diet, nutrition, and prostate cancer [J].
Clinton, SK ;
Giovannucci, E .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :413-440
[8]   Phytic acid (IP6), novel broad spectrum anti-neoplastic agent: a systematic review [J].
Fox, CH ;
Eberl, M .
COMPLEMENTARY THERAPIES IN MEDICINE, 2002, 10 (04) :229-234
[9]  
Gingrich JR, 1999, PROSTATE CANCER P D, V2, P70, DOI 10.1038/sj/pcan/4500296
[10]   A transgenic mouse prostate cancer model [J].
Gingrich, JR ;
Greenberg, NM .
TOXICOLOGIC PATHOLOGY, 1996, 24 (04) :502-504